SC 13G: Autonomix Medical, Inc.

AI Summary

SC 13G filing by Autonomix Medical, Inc..

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.001 — of class of securities. Common Stock, $0.001 par value (e) CUSIP No. 05330T 106

Filing Documents

• tm2425331d1_sc13g.htm (SC 13G) — 41KB
• 0001104659-24-106486.txt ( ) — 43KB

(a)Name of Issuer

Item 1.(a)Name of Issuer. Autonomix Medical, Inc. (b) Address of issuer’s principal executive offices. 21 Waterway Avenue, Suite 300, The Woodlands, TX 77380

(a)Name of person filing (the “Reporting

Item 2.(a)Name of person filing (the “Reporting Person” ). BioStar Ventures III, L.P. (b) Address or principal business office or, if none, residence. The address for the Reporting Person is 206 Bridge Street, Charlevoix, MI 49720 (c) Citizenship. The Reporting Person is a citizen of the United States of America. (d) Title of class of securities. Common Stock, $0.001 par value (e) CUSIP No. 05330T 106 Item 3. If this statement is filed pursuant to §§.240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a: (a) [_]Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) [_]Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [_]Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [_]Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [_]An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E). (f) [_]An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F). (g) [_]A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G). (h) [_]A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). (i) [_]A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3). (j) [_]A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J). (k) [_]Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution. 3

Ownership

Item 4. Ownership. (c) Number of Shares as to which the person has: Name (a) Amount Beneficially Owned (b) Percent of Class* Sole Power to Vote or to Direct the Vote Shared Power to Vote or to Direct the Vote Sole Power to Dispose or to Direct the Disposition of Shared Power to Dispose or to Direct the Disposition of BioStar Ventures III, L.P. 2,416,305 10.5% 2,416,305 0 2,416,305 0 * As of August 26, 2024 (based on 23,036,933 shares of the Issuer’s Common Stock outstanding as reported by the Issuer).

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class. Not applicable.

Ownership of More than Five Percent on Behalf of Another Person

Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group. Not applicable.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group. Not applicable.

Certification

Item 10. Certification. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: October 7, 2024 BioStar Ventures III, L.P. By: BioStar Ventures III, L.L.C., its general partner By: /s/Louis Cannon, MD Name: Louis Cannon, MD Title: Founder and Senior Managing Director 4

View Full Filing

View this SC 13G filing on SEC EDGAR